PharmaCyte Biotech Correlations

PMCB Stock  USD 0.74  0.04  5.71%   
The current 90-days correlation between PharmaCyte Biotech and Quoin Pharmaceuticals Ltd is 0.07 (i.e., Significant diversification). The correlation of PharmaCyte Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

PharmaCyte Biotech Correlation With Market

Modest diversification

The correlation between PharmaCyte Biotech and DJI is 0.2 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding PharmaCyte Biotech and DJI in the same portfolio, assuming nothing else is changed.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PharmaCyte Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private.
For information on how to trade PharmaCyte Stock refer to our How to Trade PharmaCyte Stock guide.

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

PLRZNBY
KTTATCRT
TCRTQNRX
BCLIVIVS
PLRZKTTA
KTTARADX
  

High negative correlations

BCLIPLRZ
PLRZQNRX
BCLINBY
BCLIKTTA
VIVSNBY
IBOQNRX

Risk-Adjusted Indicators

There is a big difference between PharmaCyte Stock performing well and PharmaCyte Biotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze PharmaCyte Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
RADX  5.83  1.10  0.12  1.15  7.52 
 7.44 
 193.18 
QNRX  7.20  0.07  0.00  0.02  0.00 
 18.69 
 77.47 
NBY  13.24  1.27  0.09  0.37  15.59 
 33.70 
 158.53 
TCRT  4.75 (0.02) 0.01  0.07  5.60 
 10.07 
 24.31 
VIVS  5.17  0.52  0.04 (0.17) 5.77 
 9.31 
 88.55 
IBO  3.92  0.01 (0.01) 0.12  4.24 
 8.00 
 61.57 
KTTA  7.52  0.71  0.09  0.34  7.85 
 13.95 
 137.41 
PLRZ  10.95  2.50  0.34  0.67  7.09 
 31.36 
 149.99 
CYCN  4.82 (0.69) 0.00 (0.27) 0.00 
 11.11 
 55.81 
BCLI  3.59 (0.16) 0.00 (0.47) 0.00 
 9.09 
 24.01 

PharmaCyte Biotech Corporate Management

CPA CPAChief OfficerProfile
HansPeter HammesMember ConsultantProfile
Jose MDConsulting OfficerProfile
HansPeter MDMember ConsultantProfile
Carlos CPAChief OfficerProfile